AMPH Covered Call Strategy

AMPH (Amphastar Pharmaceuticals, Inc.), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API.

AMPH (Amphastar Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $807.8M, a trailing P/E of 10.48, a beta of 0.97 versus the broader market, a 52-week range of 17.03-31.26, average daily share volume of 570K, a public-listing history dating back to 2014, approximately 2K full-time employees. These structural characteristics shape how AMPH stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.97 places AMPH roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 10.48 is on the value side, where IV often compresses outside event windows because forward growth expectations are already discounted into the share price.

What is a covered call on AMPH?

A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.

Current AMPH snapshot

As of May 15, 2026, spot at $16.84, ATM IV 94.50%, IV rank 17.25%, expected move 27.09%. The covered call on AMPH below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this covered call structure on AMPH specifically: AMPH IV at 94.50% is on the cheap side of its 1-year range, which means a premium-selling AMPH covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 27.09% (roughly $4.56 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AMPH expiries trade a higher absolute premium for lower per-day decay. Position sizing on AMPH should anchor to the underlying notional of $16.84 per share and to the trader's directional view on AMPH stock.

AMPH covered call setup

The AMPH covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AMPH near $16.84, the first option leg uses a $17.68 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AMPH chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AMPH shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 100 sharesStock$16.84long
Sell 1Call$17.68N/A

AMPH covered call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.

AMPH covered call payoff curve

Modeled P&L at expiration across a range of underlying prices for the covered call on AMPH. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use covered call on AMPH

Covered calls on AMPH are an income strategy run on existing AMPH stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.

AMPH thesis for this covered call

The market-implied 1-standard-deviation range for AMPH extends from approximately $12.28 on the downside to $21.40 on the upside. A AMPH covered call collects premium on an existing long AMPH position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether AMPH will breach that level within the expiration window. Current AMPH IV rank near 17.25% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on AMPH at 94.50%. As a Healthcare name, AMPH options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AMPH-specific events.

AMPH covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AMPH positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AMPH alongside the broader basket even when AMPH-specific fundamentals are unchanged. Short-premium structures like a covered call on AMPH carry tail risk when realized volatility exceeds the implied move; review historical AMPH earnings reactions and macro stress periods before sizing. Always rebuild the position from current AMPH chain quotes before placing a trade.

Frequently asked questions

What is a covered call on AMPH?
A covered call on AMPH is the covered call strategy applied to AMPH (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With AMPH stock trading near $16.84, the strikes shown on this page are snapped to the nearest listed AMPH chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are AMPH covered call max profit and max loss calculated?
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the AMPH covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 94.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a AMPH covered call?
The breakeven for the AMPH covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current AMPH market-implied 1-standard-deviation expected move is approximately 27.09%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a covered call on AMPH?
Covered calls on AMPH are an income strategy run on existing AMPH stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
How does current AMPH implied volatility affect this covered call?
AMPH ATM IV is at 94.50% with IV rank near 17.25%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related AMPH analysis